Siegfried Reich is the Senior Vice President of Research and a Co-Founder. Prior to eFFECTOR, he was a Research Fellow at the Lilly Biotech Center, San Diego, where he had oversight of fragment-based and structure-based design efforts across the Lilly discovery portfolio. Previously he was Vice President, Head of Drug Discovery at SGX; Vice President, Head of Viral and Ophthalmic Diseases at Pfizer; and Director, Head of Medicinal Chemistry at Agouron. Dr. Reich is an inventor of two marketed products (Inlyta® and Viracept®) and is responsible as inventor or team leader for numerous candidates currently in clinical development. He is a recognized leader in the application of fragment- and structure-based approaches to drug discovery and a past recipient of the PhRMA Discoverers Award. Dr. Reich completed his post-doctoral training in chemistry at the University of California, Berkeley and his Ph.D. in Chemistry at the University of California, Irvine. He received his B.S. in Chemistry from San Diego State University.